Publication | Open Access

Interleukin-15 enhances rituximab-dependent cytotoxicity against chronic lymphocytic leukemia cells and overcomes transforming growth factor beta-mediated immunosuppression

CytokineLymphoid NeoplasiaAutoimmune DiseaseMalignant Blood DisorderImmunologyImmunologic MechanismAutoimmunityImmunotherapyMedicineCell BiologyTumor Microenvironment